FDA Warns 3 Drug Compounders Over Sloppy Practices

Law360, Washington (March 4, 2014, 7:44 PM EST) -- The U.S. Food and Drug Administration on Tuesday released three warning letters it sent to drug compounding pharmacies, slamming all three for unsanitary conditions at their facilities and two for producing drugs without individual prescriptions.

Nora Apothecary and Alternative Therapies Inc., Pallimed Solutions Inc. and Wedgewood Village Pharmacy Inc. all received FDA warnings detailing the shortfalls in their sterile facility procedures, which ranged from visible sterile drug contamination to inadequate clean room facilities and monitoring programs.

In particular, Pallimed received the most the scathing FDA review, which noted that approximately 56 inspected vials contained “white filamentous material and black floaters” and...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!